(PubMed) Labunskyy VM, Ferguson AD, Fomenko DE, Chelliah Y, Hatfield DL, Gladyshev VN
Competitive Displacement: FOXO4-DRI mimics the binding site of FOXO4. It binds to p53 with high affinity, displacing the endogenous FOXO4
A 40-unit dose sits near the mid-to-high end of typical maintenance ranges, suggesting sustained treatment for weight management or metabolic benefit rather than initial titration
Severe dizziness or lightheadedness upon standing
DAILY USE - During your exercise, mix 1 scoop of TRU BCAA into a shaker or water bottle and drink as desired throughout workouts or activity
The OASIS clinical trial program evaluated oral semaglutide for chronic weight management, with results published in peer-reviewed journals